Mirax: A Brazilian X-Ray Astronomy Satellite Mission

We describe the ``Monitor e Imageador de Raios-X'' (MIRAX), an X-ray astronomy satellite mission proposed by the high energy astrophysics group at the National Institute for Space Research (INPE) in Brazil to the Brazilian Space Agency. MIRAX is an international collaboration that includes, besides INPE, the University of California San Diego, the University of Tuebingen in Germany, the Massachusetts Institute of Technology and the Space Research Organization Netherlands. The payload of MIRAX will consist in two identical hard X-ray cameras (10 -200 keV) and one soft X-ray camera (2-28 keV), both with angular resolution of ~ 5-6 arcmin. The basic objective of MIRAX is to carry out continuous broadband imaging spectroscopy observations of a large source sample (~ 9 months/yr) in the central Galactic plane region. This will allow the detection, localization, possible identification, and spectral/temporal study of the entire history of transient phenomena to be carried out in one single mission. MIRAX will have sensitivities of ~ 5 mCrab/day in the 2-10 keV band (~2 times better than the All Sky Monitor on Rossi X-ray Timing Explorer) and 2.6 mCrab/day in the 10-100 keV band (~40 times better than the Earth Occultation technique of the Burst and Transient Source Experiment on the Compton Gamma-Ray Observatory). The MIRAX spacecraft will weigh about 200 kg and is expected to be launched in a low-altitude (~ 600 km) circular equatorial orbit around 2007/2008.Comment: 6 pages, 1 table, 3 figures, presented at 2002 COSPAR meeting in Houston. Submitted to Adv. Space Re

O africanista

No abstract available

Senhor Segundamão

No abstract available

A geometric morphometric approach to the study of variation of shovel-shaped incisors

International audienc

Impactful Practice: Lessons Learned Through Ballooning Outreach

The goal of Bluegrass Community and Technical College’s (BCTC) Eclipse Outreach Ambassador Project was to get students across the Bluegrass excited and educated about the 2017 total solar eclipse. Several years ago the BalloonSat Project was started to provide hands-on earth and atmospheric science experiences to BCTC students. In linking the two initiatives, we allowed BCTC BalloonSat team members to continue learning to design, build, test, fly and retrieve balloon-borne payloads while using a novel method by which to engage local elementary and middle school students in learning more about and anticipating the upcoming eclipse. Eclipse practice flights carried payloads constructed by local K-12 STEM students. Balloon team members will discuss lessons learned in launch, flight, and recovery procedures, as well as, STEM outreach

E-cadherin and cell adhesion: a role in architecture and function in the pancreatic islet

Background/Aims: The efficient secretion of insulin from beta-cells requires extensive intra-islet communication. The cell surface adhesion protein epithelial (E)-cadherin (ECAD) establishes and maintains epithelial tissues such as the islets of Langerhans. In this study, the role of ECAD in regulating insulin secretion from pseudoislets was investigated. Methods: The effect of an immuno-neutralising ECAD on gross morphology, cytosolic calcium signalling, direct cell-to-cell communication and insulin secretion was assessed by fura-2 microfluorimetry, Lucifer Yellow dye injection and insulin ELISA in an insulin-secreting model system. Results: Antibody blockade of ECAD reduces glucose-evoked changes in [Ca2+](i) and insulin secretion. Neutralisation of ECAD causes a breakdown in the glucose-stimulated synchronicity of calcium oscillations between discrete regions within the pseudoislet, and the transfer of dye from an individual cell within a cell cluster is attenuated in the absence of ECAD ligation, demonstrating that gap junction communication is disrupted. The functional consequence of neutralising ECAD is a significant reduction in insulin secretion. Conclusion: Cell adhesion via ECAD has distinct roles in the regulation of intercellular communication between beta-cells within islets, with potential repercussions for insulin secretion. Copyright (C) 2007 S. Karger AG, Basel

Texts prepared for delivery at Paul Krugman's honorary doctorate by three Lisbon universities on 27 February, 2012

Three texts were prepared for delivery at the first honorary doctorate awarded simultaneously by three Lisbon universities on 27 February, 2012: an introduction, a lecture and a comment. The event included the award of member of the Lisbon Academy of Science (ACL) by Manuel Jacinto Nunes, dean of the economics and finance section of ACL who proposed his name and Olivier Blanchard’s on the 30th anniversary of James Tobin receiving an honorary doctorate from Nova University. On 24 February , Paul Krugman visited ACL and participated in a session of the project dubbed “Letter to the lusofonia Queen”. Since this project is promoted by Nova SBE’s Center for Globalization and Governance and has been featured in some of the graduate courses, a short note on the meeting is included in annex. On 15 June, the three universities authorized an edition in Portuguese and donated the copyrights to a student award on “Krugman economics”, in a way still to be determined by the editor. The lecture and the comment will be translated as soon as a suitable publisher is found. Since a lot of the teaching at Nova SBE is in English, it seemed appropriate to reproduce the original texts in the order in which they were presented. A lively question and answer period was also recorded by Nova TV and should be made available in the book, together with highlights of the media coverage. Introduced as a “militant economist”, he speaks about a crisis “his mind loves but does not let the heart forget the poor and the unemployed”. The Nobel prize winner described as a“progressist pessimist of the world economy” concludes with a severe indictment of the profession. “In normal times, when things are going pretty well, the world can function reasonably well without professional economic advice. It’s in times of crisis, when practical experience suddenly proves useless and events are beyond anyone’s normal experience, that we need professors with their models to light the path forward. And when the moment came, we failed”. The comment, by the official responsible for Paul Krugman’s mission to Portugal in 1976, contains an equally dire prediction: “I would very much like to see in the near future the weakening of the influence not only of freshwater economists but also of their conservative European followers. But I fear that this will not happen until we find ourselves in a more calamitous situation than at present”. Fortunately Silva Lopes closes in the hope “that the ideas of Paul Krugman will soon have more influence in policy makers than at present seems to be the case”

Laboratory Medicine is Faced with the Evolution of Medical Practice

Laboratory medicine and clinical medicine are co-dependent components of medicine. Laboratory medicine functions most effectively when focused through a clinical lens. Me dical practice as a whole undergoes change. New drugs, treatments and changes in management strategies are introduced. New techniques, new technologies and new tests are developed. These changes may be either clinically or laboratory initiated, and so their introduction requires dialogue and interaction between clinical and laboratory medicine specialists. Treatment monitoring is integral to laboratory medicine, varying from direct drug measurement to monitoring cholesterol levels in response to treatment. The current trend to »personalised medicine« is an extension of this process with the development of companion diagnostics. Technological innovation forms part of modern laboratory practice. Introduction of new technology both facilitates standard laboratory approaches and permits introduction of new tests and testing strategies previously confined to the research laboratory only. The revolution in cardiac biomarker testing has been largely a laboratory led change. Flexibility in service provision in response to changing clinical practice or evolving technology provides a significant laboratory management challenge in the light of increasing expectations, shifts in population demographics and constraint in resource availability. Laboratory medicine practitioners are adept at meeting these challenges. One thing remains constant, that there will be a constant need laboratory medicine to meet the challenges of novel clinical challenges from infectious diseases to medical conditions developing from lifestyle and longevity

Dual crosslinked pectin–alginate network as sustained release hydrophilic matrix for repaglinide

Repaglinide, an oral antidiabetic agent, has a rapid onset of action and short half–life of approximately 1 h. Developing a controlled and prolonged release delivery system is required to maintain its therapeutic plasma concentration and to eliminate its adverse effects particularly hypoglycemia. The present study aimed to develop controlled release repaglinide loaded beads using sodium alginate and pectin with dual cross–linking for effective control of drug release. The prepared beads were characterized for size, percentage drug entrapment efficiency, in vitro drug release and the morphological examination using scanning electron microscope. For the comparative study, the release profile of a marketed conventional tablet of repaglinide (Prandin® tablets 2 mg, Novo Nordisk) was determined by the same procedure as followed for beads. The particle size of beads was in the range of 698 ± 2.34 to 769 ± 1.43 μm. The drug entrapment efficiency varied between 55.24 ± 4.61 to 82.29 ± 3.42%. The FTIR results suggest that there was no interaction between repaglinide and excipients. The XRD and DSC results suggest partial molecular dispersion and amorphization of the drug throughout the system. These results suggest that repaglinide did not dissolve completely in the polymer composition and seems not to be involved in the cross–linking reaction. The percent drug release was decreased with higher polymer concentrations. In conclusion, the developed beads could enhance drug entrapment efficiency, prolong the drug release and enhance bioavailability for better control of diabetes